Speaker illustration

Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

Member of:

Heart Failure Association of the ESC

Donation after circulatory death in a European ultraperipheral and multi-insular region.

Event: ESC Congress 2025

Topic: Heart Transplantation

Session: Heart transplantation: risks, markers, and outcomes

Thumbnail

Use of vericiguat: real-world outcomes and insights from the VERITA registry.

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Improving outcomes in heart failure

Thumbnail

Pre-transplant clinical and post-transplant outcomes of patients with a novel mutation in the emerin gene

Event: ESC Congress 2025

Topic: Dilated Cardiomyopathy

Session: Precision medicine in dilated cardiomyopathy

Thumbnail

Five-year evaluation of the first heart transplant program in a European ultraperipheral region: characteristics, outcomes and implications

Event: ESC Congress 2025

Topic: Heart Transplantation

Session: Chronic heart failure: heart transplantation

Thumbnail

Albuminuria and acute heart failure. Prognostic implications and short-term mortality.

Event: ESC Congress 2025

Topic: Biomarkers

Session: Acute heart failure: new insights and treatments

Thumbnail

Prognosis changes in patients with transthyretin cardiac amyloidosis after attr-act study.

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in chronic heart failure - epidemiology, prognosis, outcome 2

Thumbnail

Prognosis value of cardiac biomarkers in transthyretin deposition cardiac amyloidosis in real life

Event: Heart Failure 2023

Topic: Biomarkers

Session: Chronic heart Failure - biomarkers 3

Thumbnail

Use of 99mTc-DPD scan in the clinical suspicion of cardiac transthyretin amyloidosis

Event: Heart Failure 2021

Topic: Diagnostic Methods

Session: ePoster session

Thumbnail

Experience of using sacubitril - valsartan in dialysis patients

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: ePoster session

Thumbnail

Use of sacubitril-valsartan in elderly patients. Subanalysis of the SAVE-RLife study

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail